Table 1.
Basic information of 4 cases of IgG4-RD in nasopharynx.
| Case | Sex | Age | Course | Manifestation | EB virus | IgG4 (mg/dL) |
IgG4+ cells/HPF | Site | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Male | 63 | 5M | Headache | – | 218 | 22 | nasopharynx | MP 40mg qd CTX 0.2g qod |
Remission |
| 2 | Male | 53 | 5M | Epistaxis, Diplopia | + | 324 | >10 | nasopharynx | MP 40mg qd CTX 50mg qd |
Remission |
| 3 | Female | 64 | 4M | Headache | + | 268 | 75 | nasopharynx | MP 40mg qd CTX 50mg qd |
Remission |
| 4 | Male | 67 | 6M | Headache | – | 765 | >10 | nasopharynx | MP 40mg qd CTX 50mg qd |
Remission |
MP, methylprednisolone; CTX, cyclophosphamide.